INTERNATIONAL PATENT: MIRADOR THERAPEUTICS, INC. FILES APPLICATION FOR "BISPECIFIC ANTIBODIES BINDING TO TL1A AND OSMR"

GENEVA, March 24 -- MIRADOR THERAPEUTICS, INC. (3115 Merryfield Rd., Suite 210San Diego, CA 92121) filed a patent application (PCT/US2025/045944) for "BISPECIFIC ANTIBODIES BINDING TO TL1A AND OSMR" on Sep 11, 2025. With publication no. WO/2026/060117, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YE, Feng (3115 Merryfield Rd., Suite 210San Diego, CA 92121)

Abstract: Described herein are bispecific antibodies which target Tumor Necrosis Factor TNF- like ligand 1 A (TL1 A) anti-oncostatin M receptor-P (OSMR). Also provi...